All In Biotech

Drug Trial Radar · NCT04912596

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

A Randomized, Single-dose, Double-blind, Double-dummy, Placebo and Active Controlled, Crossover Design Study Using Bronchoprovocation to Evaluate the Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Last checked: Nov 20, 2026Latest source record: Feb 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 148 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

148

Planned (sponsor's estimate)

Start

Aug 15, 2022

Primary completion

Jan 31, 2025

Study completion Jun 2025

Sponsor

Lead sponsor
Intech Biopharm Ltd.Industry
Sponsor type
Industry
First posted
Jun 3, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the pharmacodynamic (PD) bioequivalence (BE) of albuterol inhalers, test formulation: Albuterol Sulfate HFA inhalation aerosol 108 mcg (equal to albuterol base 90 mcg) per actuation and reference formulation: ProAir HFA (albuterol sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg (equal to albuterol base 90 mcg) per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma.

Conditions

  • Mild Asthma

Interventions

  • Albuterol Sulfate inhalation aerosol 108 mcg per actuationDrug

    equal to albuterol 90 mcg/puff, MDI

  • Proair HFA (Albuterol Sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg per actuationDrug

    equal to albuterol 90 mcg/puff, MDI

  • Proair HFA or FDA authorized generic: Albuterol Sulfate HFA Inhalation PlaceboOther

    MDI

  • Albuterol Sulfate inhalation PlaceboOther

    MDI

  • MethacholineOther

    Methacholine 100 mg/vial

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Post-dose PC20 ConcentrationTime frame: 15 minutes post-dose

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Dr. Jivraj Mehta Smarak Health Foundation

    Ahmedabad, India · Not yet recruiting

  • KLEs Dr Prabhakar Kore Hospital & MRC

    Belagāve, India · Not yet recruiting

  • NRS Medical College and Hospital

    Kolkata, India · Not yet recruiting

  • Medical College and Hospital

    Kolkata, India · Not yet recruiting

  • Aakash Healthcare Super Specialty Hospital

    New Delhi, India · Not yet recruiting

  • Pimpri Chinchwad Municipal Corporation Post Graduate Institute Yashwantrao Chavan Memorial Hospital

    Pune, India · Not yet recruiting

  • Kothrud Hospital

    Pune, India · Not yet recruiting

  • Ashirwad Hospital and Research Centre

    Ulhasnagar, India · Not yet recruiting

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan · Recruiting

  • Tamshui Mackay Memorial Hospital

    New Taipei City, Taiwan · Recruiting

  • Taipei Medical University Hospital

    Taipei, Taiwan · Recruiting

  • Shin Kong Wu Ho-Su Memorial Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.